The article APA Issues Position Statement on Psychedelics was originally published on Microdose. This past July, America’s oldest medical association,...
Researchers are comparing near-death experiences (NDE) to psychedelics-imagined “death” experiences to learn more about both. The post Psychedelics...
Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced on Tuesday that the first patient has been dosed The post MindMed Starts Dosing...
The article MindMed Doses First Patients in Phase 1 MDMA Trial was originally published on Microdose. MindMed Collaborators Dose First Subject in Phase...
The article News You Might Have Missed: Sep 19th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly...
The psychedelics industry is attracting more attention from less scrupulous operators who see the reward as worth the risk. The post Illicit Psychedelics...
Traditional psychedelics have shown great potential for treating issues like depression, anxiety, PTSD, and addiction. Psilocybin and MDMA will likely...
The article New Survey Shows Psychedelic Use At Record High was originally published on Microdose. Psychedelia has been busy stamping its imprint on the...
Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) posted positive results as revenue rose along with patients — showing the growing demand for psychedelics-centered...
The article A Look at MAPS’ Phase 3 Trials was originally published on Microdose. The first of The Multidisciplinary Association for Psychedelic’s...